Brief: Kinnate Biopharma Inc. Enters Into Agreement To Be Acquired By Xoma Corporation
16/02/2024 14:26
Feb 16 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* KINNATE BIOPHARMA INC. ENTERS INTO AGREEMENT TO BE
ACQUIRED BY
XOMA CORPORATION FOR BETWEEN $2.3352 AND $2.5879 PER SHARE IN
CASH, PLUS ONE CONTINGENT VALUE RIGHT PER SHARE
* UNIT OF XOMA WILL COMMENCE TENDER OFFER BY MARCH 4 TO
ACQUIRE
ALL OUTSTANDING SHARES OF KINNATE COMMON STOCK
Source text for Eikon: ID:nGNX1sdRvl
Further company coverage: KNTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview